APA način citiranja

Malkan, U. Y., & Haznedaroglu, I. C. (2018). Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia. Open Med (Wars).

Čikaški stil citiranja

Malkan, Umit Y., i Ibrahim C. Haznedaroglu. "Discontinuation of Imatinib Mesylate Could Improve Renal Impairment in Chronic Myeloid Leukemia." Open Med (Wars) 2018.

MLA način citiranja

Malkan, Umit Y., i Ibrahim C. Haznedaroglu. "Discontinuation of Imatinib Mesylate Could Improve Renal Impairment in Chronic Myeloid Leukemia." Open Med (Wars) 2018.